EP3846875A4 - Système et méthode pour l'élimination d'inhibiteurs immunitaires de fluides biologiques - Google Patents

Système et méthode pour l'élimination d'inhibiteurs immunitaires de fluides biologiques Download PDF

Info

Publication number
EP3846875A4
EP3846875A4 EP19920634.3A EP19920634A EP3846875A4 EP 3846875 A4 EP3846875 A4 EP 3846875A4 EP 19920634 A EP19920634 A EP 19920634A EP 3846875 A4 EP3846875 A4 EP 3846875A4
Authority
EP
European Patent Office
Prior art keywords
elimination
biological fluids
immune inhibitors
immune
inhibitors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP19920634.3A
Other languages
German (de)
English (en)
Other versions
EP3846875A1 (fr
Inventor
Steven Josephs
Matthew Ong
Amir Jafri
Robert Segal
Stephen Prince
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Immunicom Inc
Original Assignee
Immunicom Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immunicom Inc filed Critical Immunicom Inc
Publication of EP3846875A1 publication Critical patent/EP3846875A1/fr
Publication of EP3846875A4 publication Critical patent/EP3846875A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/362—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits changing physical properties of target cells by binding them to added particles to facilitate their subsequent separation from other cells, e.g. immunoaffinity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/34—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration
    • A61M1/3472—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration with treatment of the filtrate
    • A61M1/3486—Biological, chemical treatment, e.g. chemical precipitation; treatment by absorbents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3687—Chemical treatment
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/525—Tumour necrosis factor [TNF]
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/04—Liquids
    • A61M2202/0413—Blood
    • A61M2202/0415—Plasma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/75—General characteristics of the apparatus with filters

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Vascular Medicine (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Anesthesiology (AREA)
  • Cell Biology (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Organic Chemistry (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • External Artificial Organs (AREA)
EP19920634.3A 2019-11-19 2019-11-19 Système et méthode pour l'élimination d'inhibiteurs immunitaires de fluides biologiques Withdrawn EP3846875A4 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2019/062177 WO2021101519A1 (fr) 2019-11-19 2019-11-19 Système et méthode pour l'élimination d'inhibiteurs immunitaires de fluides biologiques

Publications (2)

Publication Number Publication Date
EP3846875A1 EP3846875A1 (fr) 2021-07-14
EP3846875A4 true EP3846875A4 (fr) 2021-07-14

Family

ID=75980821

Family Applications (1)

Application Number Title Priority Date Filing Date
EP19920634.3A Withdrawn EP3846875A4 (fr) 2019-11-19 2019-11-19 Système et méthode pour l'élimination d'inhibiteurs immunitaires de fluides biologiques

Country Status (8)

Country Link
EP (1) EP3846875A4 (fr)
JP (2) JP7159493B2 (fr)
KR (2) KR102491518B1 (fr)
CN (1) CN114650852B (fr)
AU (3) AU2019474912B2 (fr)
CA (2) CA3153685C (fr)
IL (2) IL301912A (fr)
WO (1) WO2021101519A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11224858B1 (en) 2020-10-01 2022-01-18 Immunicom, Inc. Reduced leaching of a ligand
WO2022071960A1 (fr) * 2020-10-01 2022-04-07 Immunicom, Inc. Lixiviation réduite d'un ligand
JP7632141B2 (ja) * 2021-07-14 2025-02-19 東レ株式会社 モジュール

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140303542A1 (en) * 2013-03-14 2014-10-09 Brian J. LeBerthon Method and device for treating cancer
WO2018020285A2 (fr) * 2016-07-28 2018-02-01 Captec Medical Kft. Dispositif de capture d'écoulement et procédé d'élimination de cellules du sang
US20190247560A1 (en) * 2018-02-13 2019-08-15 Gambro Lundia Ab Extracorporeal devices and methods of treating complement factor related diseases
WO2019167048A1 (fr) * 2018-02-28 2019-09-06 Plas-free Ltd. Dispositif extracorporel et matrice pour éliminer des protéines fibrinolytiques de liquides biologiques, méthodes et utilisations de ceux-ci

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2213079C (fr) 1995-02-16 2004-12-14 Kanegafuchi Kagaku Kogyo Kabushiki Kaisha Adsorbant du facteur .alpha. de necrose tumorale, procede permettant de l'eliminer par adsorption et dispositif d'adsorption utilisant ledit adsorbant
US8197430B1 (en) * 1998-05-22 2012-06-12 Biopheresis Technologies, Inc. Method and system to remove cytokine inhibitor in patients
JP4150838B2 (ja) * 1999-11-02 2008-09-17 株式会社カネカ 充填物流出防止用フィルタ及びそれを装着した吸着器
WO2004064608A2 (fr) * 2003-01-17 2004-08-05 Aethlon Medical, Inc. Procede de suppression de virus dans le sang par hemodialyse a affinite pour les lectines
JP2006288571A (ja) 2005-04-08 2006-10-26 Toray Ind Inc 癌治療用吸着材および体外循環カラム
JP4925159B2 (ja) * 2005-10-12 2012-04-25 日機装株式会社 血液浄化装置
DK3789056T3 (da) * 2007-08-31 2025-06-23 Seastar Medical Inc Indretninger til selektiv cytoferese
JP2009178523A (ja) 2008-02-01 2009-08-13 Kaneka Corp 可溶性腫瘍壊死因子受容体の吸着材、吸着方法および吸着装置
JP5341559B2 (ja) 2009-03-03 2013-11-13 和雄 寺本 多孔性吸着材
US9717841B2 (en) * 2012-09-11 2017-08-01 Gary L. McNeil Closed-circuit device and methods for isolation, modification, and re-administration of specific constituents from a biological fluid source
US20170014450A1 (en) 2014-02-28 2017-01-19 Exosome Sciences, Inc. Brain specific exosome based diagnostics and extracorporeal therapies
JP6480447B2 (ja) * 2014-07-22 2019-03-13 旭化成メディカル株式会社 ヒストンを除去する吸着材及び生体由来液浄化デバイス
JP2018509994A (ja) 2015-03-27 2018-04-12 エリアス・セラピューティクス・インコーポレイテッドＥｌｉａｚ Ｔｈｅｒａｐｅｕｔｉｃｓ，Ｉｎｃ． 患者選択的アフェレシス
DE102018104177A1 (de) * 2018-02-23 2019-08-29 B. Braun Avitum Ag Vorrichtung zur Entfernung von Noxen aus Blut, extrakorporales Perfusionssystem mit einer solchen Vorrichtung sowie Verfahren zur Herstellung einer solchen Vorrichtung

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140303542A1 (en) * 2013-03-14 2014-10-09 Brian J. LeBerthon Method and device for treating cancer
WO2018020285A2 (fr) * 2016-07-28 2018-02-01 Captec Medical Kft. Dispositif de capture d'écoulement et procédé d'élimination de cellules du sang
US20190247560A1 (en) * 2018-02-13 2019-08-15 Gambro Lundia Ab Extracorporeal devices and methods of treating complement factor related diseases
WO2019167048A1 (fr) * 2018-02-28 2019-09-06 Plas-free Ltd. Dispositif extracorporel et matrice pour éliminer des protéines fibrinolytiques de liquides biologiques, méthodes et utilisations de ceux-ci

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO2021101519A1 *

Also Published As

Publication number Publication date
EP3846875A1 (fr) 2021-07-14
JP2023015053A (ja) 2023-01-31
CA3165330A1 (fr) 2021-05-27
IL289438B2 (en) 2023-09-01
CN114650852B (zh) 2024-08-06
AU2019474912B2 (en) 2022-02-17
JP7159493B2 (ja) 2022-10-24
AU2022203249A1 (en) 2022-06-23
CA3153685A1 (fr) 2021-05-27
AU2019474912A1 (en) 2022-01-06
KR20220039724A (ko) 2022-03-29
KR20230016032A (ko) 2023-01-31
AU2023274130A1 (en) 2023-12-21
JP7514281B2 (ja) 2024-07-10
CA3153685C (fr) 2022-10-11
CN114650852A (zh) 2022-06-21
IL301912A (en) 2023-06-01
IL289438B1 (en) 2023-05-01
KR102491518B1 (ko) 2023-01-20
IL289438A (en) 2022-02-01
JP2022535604A (ja) 2022-08-09
WO2021101519A1 (fr) 2021-05-27
AU2022203249B2 (en) 2023-08-31

Similar Documents

Publication Publication Date Title
EP3948772A4 (fr) Méthode et système de sélection d'embryons
EP3610450A4 (fr) Système et procédé pour le traitement parallèle de transactions de chaînes de blocs
EP4038374A4 (fr) Système et procédé d'inspection visuelle par ia
EP3821313A4 (fr) Système et procédé d'identification et collecte d'objets
EP3776194A4 (fr) Procédé et système pour améliorer la performance et l'isolation de conteneurs de logiciels
EP3846875A4 (fr) Système et méthode pour l'élimination d'inhibiteurs immunitaires de fluides biologiques
EP3822630C0 (fr) Procédés et appareil pour séparer des entités biologiques
EP3680910A4 (fr) Système et procédé en nuage pour la transmission d'une ordonnance électronique
EP3876495A4 (fr) Procédé et système pour faire fonctionner un dispositif de l'internet des objets
EP3926902A4 (fr) Procédé et système de transmission de données de l'internet des objets
EP3789751A4 (fr) Procédé et système de détermination d'une concentration de plaquettes
EP3820588A4 (fr) Système et procédé pour le traitement de particules flottantes
EP4208850A4 (fr) Système et procédé pour pipeline de pancréatographie virtuelle
EP3803049A4 (fr) Procédé et système pour atténuation de glissement saccadé
EP3823561A4 (fr) Système et procédé pour fusionner des os
EP3626574A4 (fr) Procédé et système de détection d'empattement de train
EP3799661A4 (fr) Procédé et système de positionnement absolu d'un objet
EP3776469A4 (fr) Système et procédé d'association 3d d'objets détectés
EP3843793A4 (fr) Système et procédé pour la réduction de micro-organismes
EP4094120A4 (fr) Système et procédé pour améliorer l'acuité visuelle
EP3652761A4 (fr) Système et procédé de détermination de l'âge d'un transformateur
EP4225025A4 (fr) Système et procédé pour la culture de crevettes
EP3773186A4 (fr) Procédé et système pour évaluation d'un flux sanguin
EP3746909A4 (fr) Système et procédé d'assistant de domaine
EP4196056A4 (fr) Système et procédé pour le traitement et la prévention d'infections articulaires périprothétiques

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: UNKNOWN

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

17P Request for examination filed

Effective date: 20200929

A4 Supplementary search report drawn up and despatched

Effective date: 20210401

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

17Q First examination report despatched

Effective date: 20210625

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20250603